# Carotegrast Methyl in Ulcerative Colitis

> **NCT06897150** · PHASE4 · COMPLETED · sponsor: **Takayuki Yamamoto** · enrollment: 50 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Carotegrast methyl

## Key facts

- **NCT ID:** NCT06897150
- **Lead sponsor:** Takayuki Yamamoto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2025-03-15
- **Final completion:** 2025-03-15
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06897150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06897150, "Carotegrast Methyl in Ulcerative Colitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06897150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*